PortfoliosLab logoPortfoliosLab logo
HPAI vs. ERNA
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

HPAI vs. ERNA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Helport AI Ltd (HPAI) and Eterna Therapeutics Inc (ERNA). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

The year-to-date returns for both stocks are quite close, with HPAI having a -88.10% return and ERNA slightly lower at -89.07%.


HPAI

1D
2.88%
1M
-18.60%
6M
-83.34%
YTD
-88.10%
1Y
-88.59%
3Y*
5Y*
10Y*
ALL TIME*
-79.84%

ERNA

1D
-5.48%
1M
-47.69%
6M
-89.25%
YTD
-89.07%
1Y
-91.59%
3Y*
-85.19%
5Y*
-86.94%
10Y*
-64.30%
ALL TIME*
-33.20%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$350.09K$8.77M$15.38M
$79.56K$308.72K$1.26M

HPAI vs. ERNA - Yearly Performance Comparison


2026 (YTD)20252024
HPAI
Helport AI Ltd
-88.10%-24.32%-53.75%
ERNA
Eterna Therapeutics Inc
-89.07%-72.79%-83.48%

Correlation

The correlation between HPAI and ERNA is -0.01, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

-0.01

Correlation (All Time)
Calculated using the full available price history since Aug 5, 2024

0.01

Fundamentals

Market Cap

HPAI:

$18.81M

ERNA:

$1.03M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

HPAI vs. ERNA — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

HPAI
HPAI Risk / Return Rank: 33
Overall Rank
HPAI Sharpe Ratio Rank: 66
Sharpe Ratio Rank
HPAI Sortino Ratio Rank: 11
Sortino Ratio Rank
HPAI Omega Ratio Rank: 22
Omega Ratio Rank
HPAI Calmar Ratio Rank: 33
Calmar Ratio Rank
HPAI Martin Ratio Rank: 22
Martin Ratio Rank

ERNA
ERNA Risk / Return Rank: 88
Overall Rank
ERNA Sharpe Ratio Rank: 1717
Sharpe Ratio Rank
ERNA Sortino Ratio Rank: 66
Sortino Ratio Rank
ERNA Omega Ratio Rank: 88
Omega Ratio Rank
ERNA Calmar Ratio Rank: 22
Calmar Ratio Rank
ERNA Martin Ratio Rank: 66
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

HPAI vs. ERNA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Helport AI Ltd (HPAI) and Eterna Therapeutics Inc (ERNA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


HPAIERNADifference
Sharpe ratioReturn per unit of total volatility

-0.31

Sortino ratioReturn per unit of downside risk

-0.91

Omega ratioGain probability vs. loss probability

0.72

0.82

-0.11

Calmar ratioReturn relative to maximum drawdown

-0.98

-0.99

+0.01

Martin ratioReturn relative to average drawdown

-1.78

-1.47

-0.30

HPAI vs. ERNA - Sharpe Ratio Comparison

The current HPAI Sharpe Ratio is -0.91, which is lower than the ERNA Sharpe Ratio of -0.60. The chart below compares the historical Sharpe Ratios of HPAI and ERNA, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

HPAI vs. ERNA - Drawdown Comparison

The maximum HPAI drawdown since its inception was -96.40%, roughly equal to the maximum ERNA drawdown of -100.00%. Use the drawdown chart below to compare losses from any high point for HPAI and ERNA.


Loading charts...

Drawdown Indicators


HPAIERNADifference

Max Drawdown

Largest peak-to-trough decline

-96.40%

-100.00%

+3.60%

Max Drawdown (1Y)

Largest decline over 1 year

-90.13%

-93.02%

+2.89%

Max Drawdown (3Y)

Largest decline over 3 years

-99.70%

Max Drawdown (5Y)

Largest decline over 5 years

-100.00%

Max Drawdown (10Y)

Largest decline over 10 years

-100.00%

Current Drawdown

Current decline from peak

-95.84%

-100.00%

+4.16%

Average Drawdown

Average peak-to-trough decline

-66.31%

-86.20%

+19.89%

Ulcer Index

Depth and duration of drawdowns from previous peaks

49.70%

62.71%

-13.01%

Volatility

HPAI vs. ERNA - Volatility Comparison

Helport AI Ltd (HPAI) has a higher volatility of 44.27% compared to Eterna Therapeutics Inc (ERNA) at 35.09%. This indicates that HPAI's price experiences larger fluctuations and is considered to be riskier than ERNA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


HPAIERNADifference

Volatility (1M)

Calculated over the trailing 1-month period

44.27%

35.09%

+9.18%

Volatility (6M)

Calculated over the trailing 6-month period

86.82%

132.84%

-46.02%

Volatility (1Y)

Calculated over the trailing 1-year period

97.06%

154.51%

-57.45%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

106.24%

114.04%

-7.80%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

106.24%

149.29%

-43.05%

Dividends

HPAI vs. ERNA - Dividend Comparison

Neither HPAI nor ERNA has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

HPAI vs. ERNA - Financials Comparison

This section allows you to compare key financial metrics between Helport AI Ltd and Eterna Therapeutics Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

Frequently Asked Questions


HPAI and ERNA have a correlation of -0.01, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

HPAI has higher volatility (44.27%) compared to ERNA (35.09%). In terms of maximum drawdown, HPAI dropped -96.40% vs ERNA's -100.00%.

ERNA currently has the higher Sharpe Ratio (-0.60 vs -0.91), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for HPAI and ERNA

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer